BioWorld

Feb. 22, 2016

Precision medicine pushes bioinformatics to the cloud

Like seemingly everything having to do with computers these days, bioinformatics is pushing into the cloud, allowing for cheaper and more efficient computation to identify potential targets for precision medicine. Read More

Week in review

Week in Washington

Word on the street

Top biopharmaceutical collaborations in 2016

Biopharmaceutical collaborations: January 22 - February 18, 2016

Biopharmaceutical modified and terminated agreements: January 22 - February 18, 2016

Money raised by biotech in 2016 vs. 2015

Money raised by biotech: Jan. 1 - Feb. 18, 2016

The week's biggest gainers and losers

BioWorld stock report for public biotechnology companies

Today's news in brief

BioWorld

BioWorld briefs for June 11, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for June 12, 2025.

AI-generated illustration of heart and metabolic impact

Deep Apple signs big Novo deal for cardiometabolic small molecules

BioWorld

Deep Apple Therapeutics Inc. could bring in as much as $812 million in a new collaboration and license deal with Novo Nordisk A/S. The total includes an...

DNA double helix under a magnifying glass

23andme genetic privacy concerns garner Congressional scrutiny

BioWorld MedTech

The bankruptcy of genetic testing service 23andme Holding Corp. prompted a reaction from many quarters, but a June 11 Senate hearing highlighted an interest in...

3Sbio revs on with phase II data in tight PD-1/VEGF bispecific race

BioWorld

3Sbio Inc. reported interim phase II study results of its PD-1/VEGF bispecific antibody, SSGJ-707 – a “fabulous” asset, according to Pfizer Inc. CEO Albert...